RE:RE:RE:RE:RE:RE:RE:On a more serious note.....I respectfully disagree Made2Last , companies compete it's part of their DNA . Right now most of them ( big pharma ) are on the Immuno therapy train , some advancements are being made and that's super but if someone comes around with a more efficient/better treatment they will pay attention . TLT could be the one and so far they're on track to prove this . A very smart oncology researcher/doctor has switched his study to PDT ( Lung cancer ) . I consider this a big vote of confidence , i'm not a scientist ( B.A. from U . of Guelph ) but he is a top researcher in his field and he's joinining the TLT train of thought . I understand that until commercialization ( FDA approval ) this stays a speculative play but TLT has come a long way in the last few years and will be derisked tremendeously with a JV/licensing deal .
GLTA